Thematic priorities and priority lines of research of the 2013 call of the Carlos III Health Institute
Among the latests Moravia's compositions thematic priorities of the Strategic Action in Health are:
at technologies omics and those of medical image as an instrumental base on which to promote a personalized medicine based on the individual's profiles and not on the disease.
b) The clinical and translational research based on the evidence of scientific and technological knowledge.
c) Science robotic and Nanotecnology as instruments of intervention in the diagnostic and treatment processes in human diseases.
d) The development of new molecules as therapeutic weapons in pathologies with a high epidemiological prevalence.
e) The description of the human interactome and the dissection of their molecular connection networks as the etiological basis of the pathophysiological processes involved in health problems.
f) The information technology as the backbone of a global space of e-health for the development of research activities in the area of Epidemiology, Public Health and Health Services as well as in the field of organization, innovation in services and the management of the NHS.
g) The application of the evidence in clinical practice in the field of SNS Strategies.
The priority research lines described in the call are the following:
a) Molecular and cellular technologies of application to interventions on human health. It contemplates the technologies and tools necessary to generate new knowledge and its transfer to clinical practice in the health area.
1. Integrative biological research and systems.
2.º Improvements in the processes of prediction, diagnosis and monitoring of diseases and monitoring of the therapeutic response.
3. Prevention, development of new drugs and innovative therapies.
4.º Biotechnology, nanomedicine, robotics and bioengineering.
b) Translational and clinical research on human health. It focuses on the knowledge of the mechanisms involved in diseases and their transfer to clinical applications. This section establishespriorities regarding health problems and medical, surgical or rehabilitative treatment of those groups of entities whose social and health interest is more relevant, taking into account the studies on the burden of disease and personal equity.
1st neurological diseases.
2. Mental health.
3. Aging and fragility.
4. Health and gender.
5. Reproductive health.
6.º Gender violence in the health field.
7.º Pediatrics and perinatal medicine.
8. Infectious diseases.
9. Cancer.
10.º Cardiovascular diseases.
11.º Endocrine diseases.
12.º Rare diseases.
13.º Respiratory diseases.
14.º Diseases of the locomotor system and connective tissue.
15.º Liver and digestive diseases.
16.º Chronic and inflammatory diseases.
17.º Palliative care.
c) Promotion of research in public health, environmental health, occupational health and dependency and health services, for the best functional quality of life of the Spanish population. It focuses on new research methods and generation of the scientific bases necessary to support policies and decision-making, as well as improvements in the innovation capabilities of the SNS services. All this based on the most effective and efficient strategies based on scientific evidence for health promotion, prevention, diagnosis and treatment of diseases, and rehabilitation.
1.º Transfer of the results of clinical research to clinical practice.
i Quality, efficiency, sustainability and solidarity of the SNS.
ii Patient safety and incident prevention.
2. Public health.
3.º Occupational health.
4. Environmental health.
5. Dependence (associated or not with lifestyles or mental and / or physical disability).
6. Variability of clinical practice.
7.º Perception, satisfaction and quality of life.
8.º Participation and empowerment of citizen patients.
d) Research in drugs, cell therapy and clinical trials.
1.º Promotion of research in medicines and development of pharmaceutical technologies.
2. Research, development and innovation in drugs for the treatment of the most relevant diseases.
3. Research in cell therapy.
4. Clinical research without commercial interest: independent clinical trials in general and, in particular, in orphan drugs and in the pediatric population.
5. Research on non-pharmacological therapies and techniques for the relief of labor pain.
e) Research in technologies for health.
1. Telemedicine.
2nd E-health.
3. Information systems for the SNS.
4. Innovation in health services aimed at improving processes.
5.º Evaluation of sanitary services.
In general, the actions regulated in the call must be framed within the thematic areas and priority lines described.
